1958
DOI: 10.1016/s0022-3476(58)80095-5
|View full text |Cite
|
Sign up to set email alerts
|

Giant hemangioendothelioma with associated thrombocytopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1959
1959
2004
2004

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The use of corticosteroids has been a mainstay of therapy since their therapeutic benefits were first noted in 1958 during treatment of thrombocytopenia secondary to platelet sequestration (52). Corticosteroids have been shown to be antiangiogenic in a number of in vitro settings (53), however, the precise pathway of action by which corticosteroids catalyze the involution of hemangiomas is not known.…”
Section: Managementmentioning
confidence: 99%
“…The use of corticosteroids has been a mainstay of therapy since their therapeutic benefits were first noted in 1958 during treatment of thrombocytopenia secondary to platelet sequestration (52). Corticosteroids have been shown to be antiangiogenic in a number of in vitro settings (53), however, the precise pathway of action by which corticosteroids catalyze the involution of hemangiomas is not known.…”
Section: Managementmentioning
confidence: 99%
“…Surgical removal of the tumour, though effective, is hazardous. Corticosteroids have little effect on the course of this condition but may decrease capillary fragility and, occasionally, improve the platelet (Scherz et al 1958). Transfusion of fresh blood or platelet-rich plasma may be of temporary use during a crisis or surgery.…”
Section: Commentmentioning
confidence: 99%